These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17963739)

  • 21. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage.
    Martel-Pelletier J; Faure MP; McCollum R; Mineau F; Cloutier JM; Pelletier JP
    J Rheumatol; 1991 Dec; 18(12):1863-71. PubMed ID: 1724464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular extracellular matrix remodeling in cerebral aneurysms.
    Bruno G; Todor R; Lewis I; Chyatte D
    J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines.
    Cakarovski K; Leung JY; Restall C; Carin-Carlson A; Yang E; Perlmutter P; Anderson R; Medcalf R; Dear AE
    Int J Cancer; 2004 Jul; 110(4):610-6. PubMed ID: 15122596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs.
    Rainsford KD; Skerry TM; Chindemi P; Delaney K
    Vet Res Commun; 1999 Mar; 23(2):101-13. PubMed ID: 10359154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical correlation with the PA/plasmin system in septic arthritis of the knee.
    Hsieh YS; Yang SF; Lue KH; Lu KH
    Clin Orthop Relat Res; 2006 Jun; 447():172-8. PubMed ID: 16505706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage.
    Blot L; Marcelis A; Devogelaer JP; Manicourt DH
    Br J Pharmacol; 2000 Dec; 131(7):1413-21. PubMed ID: 11090115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
    Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
    Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
    Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intra-articular administration of sodium hyaluronate on plasminogen activator system in temporomandibular joints with osteoarthritis.
    Tang YL; Zhu GQ; Hu L; Zheng M; Zhang JY; Shi ZD; Liang XH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):541-7. PubMed ID: 20185343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis.
    Diehl P; Hantke B; Hennig M; Tschesche H; Mittelmeier W; Schmitt M; Muehlenweg B
    Int J Mol Med; 2004 May; 13(5):711-5. PubMed ID: 15067375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts.
    Hilal G; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
    Arthritis Rheum; 1999 Oct; 42(10):2112-22. PubMed ID: 10524682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors.
    Landau BJ; Kwaan HC; Verrusio EN; Brem SS
    Cancer Res; 1994 Feb; 54(4):1105-8. PubMed ID: 8313368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
    Saxne T; Lecander I; Geborek P
    J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
    Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
    Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of firocoxib, meloxicam, and tepoxalin on prostanoid and leukotriene production by duodenal mucosa and other tissues of osteoarthritic dogs.
    Punke JP; Speas AL; Reynolds LR; Budsberg SC
    Am J Vet Res; 2008 Sep; 69(9):1203-9. PubMed ID: 18764695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.